The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States
Abstract
OBJECTIVE. In February 2006, a safe, efficacious, orally administered pentavalent human-bovine reassortant rotavirus vaccine was licensed and recommended for routine immunization of all children in the United States. We assessed the health and economic impacts of a national rotavirus immunization program in the United States. METHODS. Monte Carlo cost-effectiveness analyses, from health care and societal perspectives, of vaccination of a hypothetical US birth cohort of 4010000 children monitored from birth to 59 months of age were performed. We compared the disease and economic burden of rotavirus infection in an unvaccinated cohort of children with one vaccinated at 2, 4, and 6 months with pentavalent human-bovine reassortant rotavirus vaccine. RESULTS. A routine rotavirus immunization program would prevent 13 deaths, 44000 hospitalizations, 137000 emergency department visits, 256000 office visits, and 1100000 episodes requiring only home care for children <5 years of age in the United States. Assuming costs of administration of $10, the break-even price per dose of vaccine was $42 from the societal perspective and $12 from the health care perspective. From the societal perspective, at the manufacturer's price of $62.50 per dose, vaccination would cost $138 per case averted, $3024 per serious case averted, and $197190 per life-year saved, at a total cost of $515 million to the health care system and $216 million to society. Key variables influencing the results were parental workdays lost, costs of hospitalization, emergency department visits, and child care. CONCLUSIONS. Despite a higher burden of serious rotavirus disease than estimated previously, routine rotavirus vaccination would unlikely be cost-saving in the United States at present. Nonetheless, rotavirus vaccination may still be considered a cost-effective intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gastroenteritis in Sentinel General Practices, the Netherlands
de Wit, M. A. S., Koopmans, M. P. G., Kortbeek, L. M., van Leeuwen, N. J., Bartelds, A. I. M., & van Duynhoven, Y. T. H. P. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010113 · Cited by 236
Cited by
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657
Self-citationSystematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis
Patel, M. M., Widdowson, M.-A., Glass, R. I., Akazawa, K., Vinjé, J., & Parashar, U. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.071114 · Cited by 953
Self-citationEconomic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
Metadata
- Authors
- Widdowson, M.-A., Meltzer, M. I., Zhang, X., Bresee, J. S., Parashar, U. D., & Glass, R. I.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2007-04-01
- Volume
- 119
- Issue
- 4
- Pages
- 684-697
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2076121434
- Cited by
- 226
- References
- 1
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States. https://app.cochat.ai/papers/10.1542/peds.2006-2876
- The paper
- Widdowson, M.-A., Meltzer, M. I., Zhang, X., Bresee, J. S., Parashar, U. D., & Glass, R. I. (2007). Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States. Pediatrics. https://doi.org/10.1542/peds.2006-2876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.